Awaiting product image

Outsourcing in Drug Discovery, 9th Edition

$5,500.00 – $11,000.00

SKU: 20-028 Categories: , Tags: , , , , , , Pages: 294

Description

Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has evolved from providing low-end research services to more value-added high-end research. Outsourcing in Drug Discovery provides an in-depth look into the trends that are shaping the drug discovery outsourcing market today, and details the current and future global market, including:

  • Global Drug Discovery Outsourcing Market, 2019 – 2024 ($ billion)
  • Contract Drug Discovery Services, by Market Segment, 2019 – 2024 (Chemistry, Biology, HTS, Lead Optimization, Total Market)
  • Market Share of Drug Discovery Market Segments, 2019, in Percent (Chemistry, Biology, HTS, Lead Optimization)
  • Market Share of Drug Discovery Market Segments, 2024, in Percent (Chemistry, Biology, HTS, Lead Optimization)
  • Chemistry Services Market
    • Chemistry Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2019 – 2024 ($ billion)
    • Chemistry Market Revenue by: Building Blocks, Compound Synthesis, Libraries, Process Research, and Other Services, 2019 ($ billion)
  • Biology Services Market
    • Biology Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2019 – 2024 ($ billion)
    • Biology Market Revenue by: Protein Expression, Structural Analysis, Target Validation, Pathways Analysis, and Other Service, 2019 ($ billion)
  • High Throughput Screening Services Market
    • HTS Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2019 – 2024 ($ billion)
    • HTS Screening Services Market: Assay Development, Primary Screening, Secondary Screening, 2019 ($ million)
  • Lead Optimization Services Market
    • Lead Optimization Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2019 – 2024 ($ billion)
    • Lead Optimization Services Market: Early ADMET/Tox, Create Analogues, Computational Support, and Other Services, 2019 ($ billion)

The pharmaceutical industry has a long history of outsourcing non-core functions. However, over the past two decades, this pattern changed as companies began routinely outsourcing a number of core functions, such clinical trial management and manufacturing. Although drug discovery is one of the more recent core functions to be outsourced, increasingly portions of the drug discovery process are being outsourced today.

Current trends in the pharmaceutical industry and broader global economy are creating new opportunities as well as challenges for drug developers. The report examines key trends that have led to an increase in demand for contract services in drug discovery, including:

  • Development of new technologies that continue to increase the number of targets and accelerate the identification of active compounds;
  • Pressure to develop new lead compounds due to the near-term loss of patent protection for many drug products;
  • Imperatives to reduce the time spent in drug discovery and bring drugs to market sooner; and
  • Increased focus on converting fixed costs to variable costs and streamlining operations by contracting research and development services.

Pharmaceutical and biopharmaceutical companies outsource to contract research organizations (CROs) certain R&D functions to gain expertise in specialized knowledge in technology for a particular therapeutic area, for clinical trials, or for regulatory affairs in a particular country or territory. Outsourcing has been used in the pharmaceutical industry for more than 20 years. However, outsourcing drug discovery functions, typically considered a core in-house function, has a more recent history. Outsourcing in Drug Discovery looks at the role of a CRO, outsourcing models, the need for effective communication for successful partnership, and the challenges of protecting IP rights.

The globalization of contract drug discovery is advancing quickly. A growing number of international CROs have expanded into Asia through alliances or acquisitions, while others are building new facilities in Asia. The report explores the robust growth of outsourcing drug discovery in Asia, specifically outsourcing to China and India. Outsourcing to Eastern Europe is examined as well.

Outsourcing in Drug Discovery provides profiles containing history and lines of business, drug discovery services, and financial data of the following competitors in the market:

  • Albany Molecular Research, Inc.
  • Aptuit, a Division of Evotec AG
  • Asclepia MedChem Solutions
  • Asinex Ltd.
  • AsisChem Inc.
  • Aurelia Bioscience Ltd
  • Axxam SpA
  • BioDuro
  • Charles River Laboratories, Inc.
  • Charnwood Molecular
  • ChemBridge Corp.
  • Chemical Diversity Inc. (ChemDiv)
  • ChemPartner Co., Ltd., subsidiary of ShangPharma
  • Chengdu Pioneer Drug Development Co., Ltd.
  • Covance Inc. (Laboratory Corporation of America)
  • CreaGen Biosciences, Inc.
  • Crown Bioscience
  • Cyprotex PLC, an Evotec AG Company
  • Domainex
  • Enamine Ltd.
  • Eurofins Scientific S.E.
  • Evotec AG
  • Exelgen Discovery
  • GVK Biosciences Private Limited (GVK Bio)
  • GenScript USA Inc.
  • Hutchison MediPharma, Ltd.
  • Jubilant Biosys Ltd. (JBL), a subsidiary of Jubilant Life Sciences Ltd.
  • Nanosyn, Inc.
  • Olon Ricerca Biosciences
  • Pharmaron, Inc.
  • Selcia Ltd
  • Selvita S.A.
  • Shanghai Medicilon, Inc.
  • Sundia MediTech Company, Ltd.
  • Sygnature Discovery Limited
  • TCG Lifesciences Pvt Ltd.
  • Viva Biotech, Ltd.
  • WuXi AppTec Co. Ltd.

In today’s environment, no market report would be complete without discussion of the impact of the outbreak of coronavirus and its resultant disease, COVID-19. The report examines the impact of the virus across a spectrum of issues affecting the outsourcing market:

  • Global Macro Trends and Coronavirus
  • Supply Chain Impact of Coronavirus
  • Cultural Implications of Coronavirus
  • R&D Spending and Impact of Coronavirus
  • Opportunities Created by the Coronavirus
  • Issues Related to Coronavirus in Terms of Outsourcing to China, India, or Eastern Europe

Table of Contents

1: Executive Summary
Overview

    • Exhibit 1-1: Drug Discovery Timeline: Research to Viable Product to Commercialization

Scope and Methodology
Introduction

  • Global Macro Trends and Coronavirus
  • Pharmaceutical Industry Trends
  • Net Effects of the Coronavirus

The Drug Discovery Process

    • Exhibit 1-2: The Drug Discovery Process
  • Bottlenecks within the Drug Discovery Process

Outsourcing Drug Discovery

  • Outsourcing to Increase Efficiency

Offshoring Contract Drug Discovery

  • Factors to Consider in Offshore Outsourcing
  • Outsourcing to China
  • Outsourcing to India
  • Outsourcing to Eastern Europe

Drug Discovery Outsourcing Market

  • Current Market and Forecast
    • Exhibit 1-3: Global Drug Discovery Outsourcing Market, 2014 – 2024 ($ billion)
  • Market Analysis by Segment
    • Exhibit 1-4: Market Share Drug Discovery Market Segments, 2019 (%; Lead Optimization, Chemistry Services, Biology Services, HTS)

2: Introduction to Outsourcing Drug Discovery
Macroeconomic Environment

  • The Coronavirus Economy
  • Supply Chain Impact of Coronavirus
  • Lifting of Lockdowns
  • Cultural Implications of Coronavirus

Biopharma Background

  • Number of New Molecular Entities (NMEs) and Biologics License Approved (BLAs) Approved
    • Exhibit 2-1: Number of New Molecular Entities (NMEs) and Biologics License Approved (BLAs) That the US FDA Center for Drug Evaluation and Research (CDER) Approved between 2000 – 2019
  • R&D Spending and Impact of Coronavirus
  • Rising Availability of Talent
  • Ramping up the Pipelines
    • Exhibit 2-2: Domestic R&D and R&D Abroad, PhRMA Member Companies: 2000 ñ 2018 ($ billion)

Outsourcing Drug Discovery
The Outsourcing Decision

  • Developing an Outsourcing Plan
  • Decision Criteria

Factors to Consider in Offshore Outsourcing

  • Benefits of Global Outsourcing
  • Concerns about Global Outsourcing

Selecting a Contract Research Organization

  • Introduction
  • Choosing the Right CRO

Global Outsourcing

    • Exhibit 2-3: Selection of Global Drug Discovery Outsourcing Collaborations, 2020

3: The Drug Discovery Process
Introduction

    • Exhibit 3-1: The Drug Discovery Process
  • Drug Discovery Stages

Accelerating the Drug Discovery Process

  • Technologies Utilized in Drug Discovery
    • Exhibit 3-2: Drug Discovery Timeline: Research to Viable Product to Commercialization
    • Exhibit 3-3: Bioinformatics/Pharmacogenomics
    • Exhibit 3-4: Causes of New Drug Attrition (%; Unsuitable Bioavailability Profile, Toxicity, Commercial Setbacks, Other)
  • Bottlenecks within the Drug Discovery Process

Outsourcing to Increase Efficiency

    • Exhibit 3-5: Drug Discovery Processes Frequently Outsourced

Outsourcing to Access Novel Technologies

  • Bioinformatics
  • Lab-on-a-Chip: Microfluidics in Drug Discovery
    • Exhibit 3-6: Bioinformatics as a Central Hub

4: Outsourcing Drug Discovery
Overview

  • Sales Decline from Lockdown Recession
  • Opportunities Created by the Coronavirus
  • Shifting Drug Discovery Model
    • Exhibit 4-1: A Selection of R&D Facilities Closed or Reduced in Size between 2010 and 2019

Outsourcing Drug Discovery Useful Core Management Tool
Contract Research Organizations

  • Introduction
  • Role of a CRO
  • Outsourcing Models
  • Effective Communication Is Essential for a Successful Partnership
  • Mitigating the Challenges of Protecting IP Rights

Outsourcing Contract Drug Discovery Offshore

  • Introduction
  • Robust Growth of Outsourcing Drug Discovery in Asia

Outsourcing to China

  • Introduction
  • Multi-National Pharmaceutical Companies Establish Research and Development Facilities in China
  • Chinese Contract Research Organizations
    • Exhibit 4-2: A Selection of Chinese Drug Discovery CROs, 2020
  • WuXi AppTec, Chinaís Largest CRO
  • First Chinese CRO Alliance
  • FDA Offices in China
  • China’s Management of Counterfeit Pharmaceuticals, IP Rights and Laws
  • Issues Related to Coronavirus
  • Slowing Economic Growth

Outsourcing to India

  • Introduction
  • Drug Discovery Services in India
    • Exhibit 4-3: A Selection of Indian Drug Discovery CROs, 2020
  • Indiaís Handling of IP Rights and Laws
  • FDA Offices in India
  • Issues Related to Coronavirus
  • Strong Historic Economic Growth

Outsourcing to Eastern Europe

  • Introduction
  • Eastern European CROs
  • Issues Related to Coronavirus
    • Exhibit 4-4: A Selection of Major CROs Operating in Eastern Europe, 2020

5: Drug Discovery Outsourcing Market
Overview
Drug Discovery Outsourcing Market

  • Current Market and Forecast
    • Exhibit 5-1: Global Drug Discovery Outsourcing Market, 2014 – 2024 ($ billion)
    • Exhibit 5-2: Contract Drug Discovery Services, by Market Segment, 2014 – 2024 ($ billion)

Market Analysis by Segment

    • Exhibit 5-3: Market Share of Drug Discovery Market Segments, 2014, in Percent
    • Exhibit 5-4: Market Share of Drug Discovery Market Segments, 2019, in Percent
    • Exhibit 5-5: Market Share of Drug Discovery Market Segments, 2024, in Percent
  • Chemistry Services Market
    • Exhibit 5-6: Chemistry Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2014 – 2024 ($ billion)
    • Exhibit 5-7: Chemistry Market Revenue by: Building Blocks, Compound Synthesis, Libraries, Process Research, and Other Services, 2019 ($ billion)
  • Biology Services Market
    • Exhibit 5-8: Biology Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2014 – 2024 ($ billion)
    • Exhibit 5-9: Biology Market Revenue by: Protein Expression, Structural Analysis, Target Validation, Pathways Analysis, and Other Services, 2019 ($ billion)
  • High Throughput Screening Services Market
    • Exhibit 5-10: HTS Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2014 – 2024 ($ billion)
    • Exhibit 5-11: HTS Screening Services Market: Assay Development, Primary Screening, Secondary Screening, 2019 ($ million)
  • Lead Optimization Services Market
    • Exhibit 5-12: Lead Optimization Services Market: Revenues, Annual Growth, and Share of Outsourced Drug Discovery Market, 2014 – 2024 ($ billion)
    • Exhibit 5-13: Lead Optimization Services Market: Early ADME/Tox, Create Analogues, Computational Support, and Other Services, 2019 ($ billion)

Contract Drug Discovery Competitors

  • Recent Acquisitions in Drug Discovery Outsourcing, 2014 – 2020

The Evolving Open-Innovation Model Gaining Traction in Drug Discovery

  • Alliances between Academic Organizations and CROs
    • Exhibit 5-14: A Selection of Collaborations between CROs and Academic Organizations, 2020
  • Alliances between the Pharmaceutical/Biotechnology Industries and Academia
    • Exhibit 5-15: Alliances between Pharma/Biotech and Academia, 2020
  • Alliances between CROs
    • Exhibit 5-16: A Selection of Alliances between CROs, 2020

Market Growth Expanding Global Reach and Scale of Drug Discovery Services

    • Exhibit 5-17: Global Expansion of Contract Drug Discovery Services East and West, 2020

Is Artificial Intelligence (AI) the Future of Drug Discovery?

  • Evotec Buys into AI
  • Pharmaceutical Companies Collaborate with AI Companies
    • Exhibit 5-18: Selected Biopharmaceutical AI Providers, 2020

6: Competitor Profiles
Albany Molecular Research, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Aptuit, a Division of Evotec AG

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Asclepia MedChem Solutions

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Asinex Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

AsisChem Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Aurelia Bioscience Ltd

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Axxam SpA

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

BioDuro

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Charles River Laboratories, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Charnwood Molecular

  • History and Background
  • Drug Discovery Services
  • Financial Data

ChemBridge Corp.

  • History and Background
  • Drug Discovery Services
  • Financial Data

Chemical Diversity Inc. (ChemDiv)

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

ChemPartner Co., Ltd., subsidiary of ShangPharma

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Chengdu Pioneer Drug Development Co., Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Covance Inc. (Laboratory Corporation of America)

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

CreaGen Biosciences, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Crown Bioscience

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Cyprotex PLC, an Evotec AG Company

  • History and Line of Business
  • Drug Discovery Services
  • Financial Data

Domainex

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Enamine Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Eurofins Scientific S.E.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Evotec AG

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Exelgen Discovery

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

GVK Biosciences Private Limited (GVK Bio)

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

GenScript USA Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Hutchison MediPharma, Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Jubilant Biosys Ltd. (JBL), a subsidiary of Jubilant Life Sciences Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Nanosyn, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Olon Ricerca Biosciences

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Pharmaron, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Selcia Ltd

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Selvita S.A.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Shanghai Medicilon, Inc.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Sundia MediTech Company, Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Sygnature Discovery Limited

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

TCG Lifesciences Pvt Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Viva Biotech, Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

WuXi AppTec Co. Ltd.

  • History and Lines of Business
  • Drug Discovery Services
  • Financial Data

Appendix: Company Names and Addresses
Company Names and Addresses

  • 2-y Chem, Ltd.
  • Abgenix
  • AbMax Biotechnology
  • Absorption Systems
  • Acesys Pharmatech
  • Actimus Biosciences Pvt. Ltd.
  • ActivX Biosciences
  • Advinus Therapeutics Pvt. Ltd.
  • Advinus Therapeutics Ltd.
  • Agios Pharmaceuticals
  • Albany Molecular Research, Inc.
  • Advinus Therapeutics Ltd.
  • Affinium Pharmaceuticals
  • Albermarle Corp.
  • Alphora Research Inc.
  • Ambit Biosciences Corp.
  • Amgen, Inc.
  • Antabio Pharmaceutical
  • Apredica
  • Aptuit, LLC
  • Asclepia
  • Asinex Ltd.
  • Asinex
  • AsisChem, Inc.
  • Astex Therapeutics
  • AstraZeneca
  • Asymchem Laboratories Co., Ltd.
  • Asymchem Laboratories Inc.
  • Aurelia Bioscience Ltd
  • Aurigene Discovery Technologies Ltd.
  • Aurigene Discovery Technologies Limited
  • Axxam SpA
  • Berg Health
  • BioAnaLab Limited
  • BioBlocks Incorporated
  • Biocentrum Cell Laboratories, a division of Selvita S.A.
  • Biocius Life Sciences, Inc.
  • BioDuro, Inc.
  • BioDuro, Inc./China
  • Biogen Idec
  • Biolog, Inc.
  • Bioneeds
  • Bionomics Ltd.
  • BioReliance Corporation
  • Biovays SAS
  • BioVisioN AG
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • British Columbia Cancer Agency
  • Caliper Life Sciences
  • Cambridge Antibody
  • Cambridge Major Laboratories, Inc
  • Cantab Biopharmaceuticals Ltd,
  • CarysBio Holding Ltd.
  • Cayman Chemical
  • Celera Genomics
  • CellCentric Ltd.
  • Cell & Molecular Technologies
  • Cellzome AG
  • Cellzome (UK)
  • Cetek Corp.
  • Eurofins Advinus Limited
  • Charles River Laboratories, Inc.
  • Charnwood Molecular
  • Charnwood Molecular
  • Chemizon, Inc.
  • ChemPartner Co., Ltd.
  • Chiesi Farmaceutici SP
  • Chembiotek
  • ChemBridge Corp.
  • ChemDiv
  • Chemizon, Inc.
  • Chemizon Ltd
  • ChemModeling, LLC
  • Chemotargets SL
  • ChemOvation Ltd.
  • ChemShop BV
  • ComGenex Inc.
  • Compugen
  • Covance, Inc
  • CreaGen Biosciences, Inc.
  • Creative BioStructure
  • Cresset Drug Discovery
  • Crown Bioscience Inc.
  • Crown Bioscience Inc./China
  • CuraGen Corp.
  • Cychem, Inc.
  • Cyprotex PLC
  • Dalton Chemical Laboratories Inc.
  • Debiopharm International SA
  • Deltagen
  • DiscoveryBioMed, Inc.
  • Domainex
  • DoubleTwist Inc.
  • Dr. Reddyís Laboratories, Ltd.
  • Dr. Reddyís Laboratories, Inc.
  • Dynogen Pharmaceuticals, Inc.
  • EM Industries, Inc.
  • Elan Pharmaceuticals
  • ElexoPharm GmbH
  • Ely Lilly and Company
  • Emerald Biostructures
  • Enamine LLC
  • Enamine Ltd.
  • Endo Pharmaceutical
  • Ensemble Discovery Corporation
  • Epiclone, L.A.
  • Evolus Inc.
  • Evotec AG
  • Evotec AG
  • Evotec (Asia) Pte. Ltd.
  • Evotec (India) Private Limited
  • Exelgen Discovery
  • Exscientia
  • ExonHit Therapeutics SA
  • ExSAR
  • Flourous Technologies
  • GPC Biotech AG
  • GVK Biosciences Private Ltd.
  • GVK Biosciences Private Ltd.
  • GVK Biosciences Private Ltd.
  • Galapagos NV
  • GeneFormatics Inc.
  • Gene Logic Inc.
  • GenScript USA Inc.
  • GenScript Biotech Corporation
  • GlaxoSmithKline
  • Genentech, Inc.
  • Genome Therapeutics
  • GeneProt
  • Genome BioSciences, Inc.
  • Genomics Collaborative Inc.
  • Genops Bioinformatics Inc.
  • GenOway
  • GenScript USA Inc.
  • GenScript/Japan
  • GenScript/China
  • Genta, Inc.
  • Genezyme Corporation
  • Gilead Sciences
  • Glaucus Proteomics BV
  • Graffinity Pharmaceuticals GmbH
  • Gr¸nenthal Group
  • HD Biosciences, Inc.
  • HitGen Ltd.
  • Human Genome Sciences
  • Hutchison MediPharma Limited
  • Hybrigen
  • Hybrigenics SA
  • Icagen, Inc.
  • Iconix Pharmaceuticals, Inc.
  • ICOS Corporation
  • ID Business Solutions Ltd.
  • Indus Bioscience
  • Informax Inc.
  • iNovacia
  • Inpharmatica
  • Insilico
  • InterChem
  • iThemba Pharma
  • Johnson Matthey Pharma Services
  • J-Star Research
  • Janssen Pharma
  • Johnson & Johnson
  • Jubilant Life Sciences Ltd.
  • Julilant Biosys Ltd.
  • Julilant Discovery Center (Noida)
  • Kalexsyn
  • Kendle International
  • Key Organics Ltd.
  • Laboratory Corporation of America Holdings
  • Lancaster Laboratories
  • Lark Technologies, Inc.
  • Laxai Corporation
  • Laxai Avanti Life Sciences
  • Lexicon Genetics Inc.
  • Life Chemicals Inc.
  • Linden Bioscience
  • Ligand Pharmaceuticals, Inc.
  • Magellan Laboratories
  • Maybridge plc
  • Medarex
  • Medicilon, Inc.
  • Medicilon, Inc.
  • Merck KGaA
  • MerLion Pharmaceuticals Pte Ltd
  • Merrimack Pharmaceuticals, Inc.
  • Metabometrix Ltd.
  • Metabometrix Ltd.
  • Micron Technologies, Inc.
  • Morphochem AG
  • MPI Research
  • Multispan, Inc.
  • Myriad Genetics Inc.
  • Naeja Pharmaceutical Inc.
  • Nanostream, Inc.
  • Nanosyn, Inc.
  • Navigen Pharma
  • NEOMED Institute
  • Neurodegeneration Consortium
  • Nextgen Sciences Ltd.
  • Nicholas Piramal India Limited
  • NiKem Research s.r.l.
  • NitroMed, Inc.
  • Novartis Institute of BioMedical Research
  • Numerate, Inc.
  • Nycomed GmbH
  • OncoDesign SA
  • OpGen
  • Organix Inc.
  • Organomed Corp.
  • Orion Pharmaceuticals
  • Oxford GlycoSciences Plc
  • Parexel
  • Pcovery
  • Peakdale Molecular Ltd.
  • PepTech Corporation
  • Pfizer, Inc.
  • PharmaCore
  • PharmaLink
  • Pharmaron
  • Pharmaron Beijing Co., Ltd.
  • Pharmaron Beijing Limited Co.
  • PharmEco
  • Pharmidex
  • Phenomix Corp.
  • Phylos Inc.
  • Polyphor Ltd
  • PPD, Inc.
  • PRECOS Ltd.
  • Prestwick Chemical
  • Procter and Gamble Company
  • Protein Mechanics, Inc.
  • Proteome Systems Ltd.
  • Proteologics Ltd.
  • ProteoMetrics Inc.
  • Protogene Laboratories Inc.
  • Provid Pharmaceuticals Inc.
  • Purely Proteins
  • Pyxis Discovery
  • Quantum Pharmaceuticals
  • Quintiles Transnational Corp.
  • Regulus Therapeutics
  • Reliance Life Sciences
  • Renovis
  • Rib-X Pharmaceuticals
  • Ricerca, LLC
  • RMC Biosciences, Inc.
  • Roche R&D Center Ltd.
  • Sai Advantium Pharma Ltd.
  • Scottish Biomedical
  • Scynexis, Inc.
  • Selcia Limited
  • SelciaWest
  • Selvita S.A.
  • Sequenom
  • Sequitur, Inc.
  • Shanghai GenMed
  • Shanghai Genomics
  • Shanghai LeadChem, subsidiary of Shanghai LeadDiscovery Pharmaceutical, Ltd.
  • Shanghai LeadDiscovery Pharmaceutical, Ltd.
  • Shanghai Medicilon
  • Shanghai United PharmaTech
  • Shasun Pharmaceuticals Ltd.
  • Shenogen Pharma Group
  • Shionogi & Co., Ltd.
  • Shire plc
  • Signature BioScience Inc.
  • Simulations Plus, Inc.
  • SomaLogic Inc.
  • Southern Research Institute
  • SPECS
  • Spectrum Bioscience
  • SRI Biosciences
  • Structural Bioinformatics, Inc.
  • Structural GenomiX
  • Sun Pharma Advanced Research Company
  • Sundia MediTech Company, Ltd./China
  • Sundia MediTech Company, Ltd.
  • Sunesis Pharmaceuticals
  • Suven Life Sciences Ltd
  • Sygnature Discovery Limited
  • Synaptica Ltd.
  • Syngene International Pvt. Ltd./India
  • Syngene International Pvt. Ltd.
  • Syrrx
  • TCG Lifesciences Limited
  • Targeted Molecules Corp.
  • Torcan Chemical Ltd.
  • Transform Pharmaceuticals Inc.
  • Venturepharm Group
  • Vertex Pharmaceuticals Inc.
  • Viva Biotech Ltd.
  • Vivo Biosciences Inc.
  • WIL Research U.S.
  • WIL Research Europe/The Netherlands
  • WIL Research Europe/France
  • WIL Research/UK
  • WuXI AppTec Co. Ltd.
  • WuXi AppTec, Inc.
  • WuXi AppTec, Inc.
  • Xencor
  • Yangtze River Pharmacy Group Co
  • ZoBio BV
  • Zygogen, LLC

Related products

Cell Therapy and Gene Therapy MarketsKalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical...